London, United Kingdom (PressExposure) December 28, 2009 -- The nucleus replacement market is forecast to be driven by a growing awareness of nonâfusion technologies in spinal surgery. This early stage market with most products under the pipeline expected to release in the next couple of years, is touted to position itself as the gold standard for the treatment of early stage disc degeneration.
It is estimated that 85% of the population over the age of 60 show evidence of spinal disc degeneration. Nucleus replacement will be the leading motion preserving treatment option in the US and Europe that holds a large pool of this aging population. Nucleus replacement technique is less invasive, less traumatic and most importantly, offers motion preservation. These factors will aid in positioning nucleus replacement as a dominant driver in the spinal surgery market.
This analysis was taken from a research paper published by GlobalData, to download the full Research Paper for free, click below:
Access the latest Orthopedic Devices analysis for free at http://www.researchviews.com
ResearchViews is your number one portal for industry related news, research, analysis and deals data. ResearchViews offers up to the minute content produced by an expert team of industry analysts.
All content on the site is free to view and allows users to keep up to date with the latest developments in their chosen industry. Free daily and weekly newsletters provide a snapshot of the major issues affecting the industry. The site also features a research store, providing the user with access to premium business intelligence from some of the world's leading market research publishers.